BIOMEA FUSION ($BMEA) is expected to release its quarterly earnings data on Tuesday, April 1st after market close, per Finnhub. Analysts are expecting revenue of $0 and earnings of -$0.94 per share.
You can see Quiver Quantitative's $BMEA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOMEA FUSION Insider Trading Activity
BIOMEA FUSION insiders have traded $BMEA stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BMEA stock by insiders over the last 6 months:
- MICHAEL J.M. HITCHCOCK purchased 10,000 shares for an estimated $100,600
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BIOMEA FUSION Hedge Fund Activity
We have seen 58 institutional investors add shares of BIOMEA FUSION stock to their portfolio, and 54 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 1,354,087 shares (-98.2%) from their portfolio in Q4 2024, for an estimated $5,253,857
- BAKER BROS. ADVISORS LP removed 656,959 shares (-31.2%) from their portfolio in Q4 2024, for an estimated $2,549,000
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 400,000 shares (-44.4%) from their portfolio in Q4 2024, for an estimated $1,552,000
- TWO SIGMA ADVISERS, LP added 341,900 shares (+290.7%) to their portfolio in Q4 2024, for an estimated $1,326,572
- TWO SIGMA INVESTMENTS, LP added 286,049 shares (+104.4%) to their portfolio in Q4 2024, for an estimated $1,109,870
- RENAISSANCE TECHNOLOGIES LLC added 261,432 shares (+317.7%) to their portfolio in Q4 2024, for an estimated $1,014,356
- WALLEYE CAPITAL LLC added 235,680 shares (+inf%) to their portfolio in Q4 2024, for an estimated $914,438
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIOMEA FUSION Analyst Ratings
Wall Street analysts have issued reports on $BMEA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 10/31/2024
- H.C. Wainwright issued a "Buy" rating on 10/22/2024
- EF Hutton issued a "Buy" rating on 10/09/2024
To track analyst ratings and price targets for BIOMEA FUSION, check out Quiver Quantitative's $BMEA forecast page.
BIOMEA FUSION Price Targets
Multiple analysts have issued price targets for $BMEA recently. We have seen 4 analysts offer price targets for $BMEA in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- An analyst from Oppenheimer set a target price of $10.0 on 03/24/2025
- Joseph Catanzaro from Piper Sandler set a target price of $19.0 on 10/31/2024
- Peter Lawson from Barclays set a target price of $11.0 on 10/30/2024
- Joseph Pantginis from H.C. Wainwright set a target price of $40.0 on 10/22/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
